The KM-plotter analysis compared the FPS and OS of GC patients in later stages (stage III or IV), whereby high PVT1 expression patients only received gastrectomy and patients with high PVT1 expression received both gastrectomy and 5-Fu based adjuvant (or other non-5-fu based drug). This evidence concerns the gene PVT1 and gastric cancer.